inforMED
InjuryLSL

APTIMA COMBO 2 ASSAY

Received Jul 23, 2025 · Event occurred Jun 4, 2025

Report 2024800-2025-00046 · MDR key 22579957

Device

Generic name

Dna-reagents, Neisseria

Manufacturer

Hologic, Inc.

Catalog number

PRD-05571

Lot number

917189

Product problems

  • Off-Label Use
  • Off-Label Use

Patient

NA · Unknown

  • No Clinical Signs, Symptoms or Conditions
  • No Clinical Signs, Symptoms or Conditions

Narrative

Description of Event or Problem

ON (B)(6) 2025, A CUSTOMER REPORTED TO HOLOGIC THAT THEY RECEIVED DISCREPANT RESULTS FOR TWO SAMPLE IDS (SIDS) (B)(6) WHILE USING THE APTIMA COMBO 2 ASSAY MASTER LOT 917189. ON (B)(6) 2025, CUSTOMER ORIGINALLY RAN SID (B)(6) ON THE PANTHER PLUS INSTRUMENT SN (B)(6) ON WORKLIST (WL) (B)(4), WHICH RESULTED IN CT POSITIVE AND GC POSITIVE. THE SAME SAMPLE WAS LATER RERUN ON THE PANTHER PLUS INSTRUMENT SN (B)(6) ON (B)(6) 2025, ON WL (B)(4) AND RESULTED CT NEGATIVE AND GC NEGATIVE. LIKEWISE, ON (B)(6) 2025, CUSTOMER ORIGINALLY RAN SID (B)(6) ON WL (B)(4), WHICH PRODUCED A DUAL CT/GC POSITIVE RESULT. THE SAME SAMPLE WAS RERUN ON THE PANTHER PLUS INSTRUMENT SN (B)(6) ON (B)(6) 2025, ON WL (B)(4) AND PRODUCED A DUAL CT/GC NEGATIVE RESULT. PER CUSTOMER LAB POLICY, THE SAMPLE IS RETESTED IF THERE IS A DUAL CT/GC POSITIVE RESULT. CUSTOMER CONFIRMED THE DUAL CT/GC NEGATIVE RESULT WAS REPORTED OUT. HOLOGIC HAS NOT BEEN INFORMED OF ANY PATIENT TREATMENT OR ANY ADVERSE PATIENT OUTCOMES RELATED TO THIS EVENT.

Additional Manufacturer Narrative

HOLOGIC TECHNICAL SUPPORT REVIEWED ALL CUSTOMER WORKLISTS AND NOTED NO INDICATIONS OF HARDWARE, REAGENT PREPARATION, OR CONTAMINATION ISSUES. HOLOGIC PERFORMED A RISK ASSESSMENT AND NOTED NO PRODUCT IMPACT. HOLOGIC HAS NOT BEEN INFORMED OF ANY ADVERSE PATIENT OUTCOMES RELATED TO THIS ISSUE.

Description of Event or Problem

FOLLOW-UP REPORT. SEE SECTION H11.

Additional Manufacturer Narrative

THE EVENT DESCRIPTION IN THE INITIAL REPORT CONTAINED AN ERROR IN THE LISTING OF THE TWO AFFECTED SAMPLE IDS (SIDS) WITHIN THE FIRST SENTENCE ONLY. THE CORRECTED EVENT DESCRIPTION IS AS FOLLOWS: ON JULY 7, 2025, A CUSTOMER REPORTED TO HOLOGIC THAT THEY RECEIVED DISCREPANT RESULTS FOR TWO SAMPLE IDS (SIDS) (B)(6) WHILE USING THE APTIMA COMBO 2 ASSAY MASTER LOT 917189. ON (B)(6) 2025, CUSTOMER ORIGINALLY RAN SID (B)(6) ON THE PANTHER PLUS INSTRUMENT SN (B)(6) ON WORKLIST (WL) 003382-20250602-05, WHICH RESULTED IN CT POSITIVE AND GC POSITIVE. THE SAME SAMPLE WAS LATER RERUN ON THE PANTHER PLUS INSTRUMENT SN (B)(6) ON (B)(6) 2025, ON WL 010208-20250604-12 AND RESULTED CT NEGATIVE AND GC NEGATIVE. LIKEWISE, ON (B)(6) 2025, CUSTOMER ORIGINALLY RAN SID (B)(6) ON WL 003382-20250603-03, WHICH PRODUCED A DUAL CT/GC POSITIVE RESULT. THE SAME SAMPLE WAS RERUN ON THE PANTHER PLUS INSTRUMENT SN (B)(6) ON (B)(6) 2025, ON WL 002484-20250605-20 AND PRODUCED A DUAL CT/GC NEGATIVE RESULT. PER CUSTOMER LAB POLICY, THE SAMPLE IS RETESTED IF THERE IS A DUAL CT/GC POSITIVE RESULT. CUSTOMER CONFIRMED THE DUAL CT/GC NEGATIVE RESULT WAS REPORTED OUT. HOLOGIC HAS NOT BEEN INFORMED OF ANY PATIENT TREATMENT OR ANY ADVERSE PATIENT OUTCOMES RELATED TO THIS EVENT.